See more : JAPAN M&A SOLUTION INCORPORATED (9236.T) Income Statement Analysis – Financial Results
Complete financial analysis of Filament Health Corp. (FH.NE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Filament Health Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Cohen & Steers, Inc. (CNS) Income Statement Analysis – Financial Results
- Imdex Limited (IMD.AX) Income Statement Analysis – Financial Results
- Points.com Inc. (PTS.TO) Income Statement Analysis – Financial Results
- THN Corporation (019180.KS) Income Statement Analysis – Financial Results
- Apollomics, Inc. (APLMW) Income Statement Analysis – Financial Results
Filament Health Corp. (FH.NE)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://filament.health
About Filament Health Corp.
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 2.13M | 364.50K | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 913.65K | 0.00 |
| Gross Profit | 2.13M | 364.50K | -913.65K | 0.00 |
| Gross Profit Ratio | 100.00% | 100.00% | 0.00% | 0.00% |
| Research & Development | 793.55K | 839.16K | 476.60K | 0.00 |
| General & Administrative | 5.09M | 4.01M | 5.07M | 166.59K |
| Selling & Marketing | 430.59K | 829.61K | 639.34K | 24.50K |
| SG&A | 5.52M | 4.84M | 5.71M | 191.10K |
| Other Expenses | 0.00 | 13.65K | 18.75K | 0.00 |
| Operating Expenses | 6.43M | 5.88M | 6.36M | 191.10K |
| Cost & Expenses | 6.43M | 5.88M | 7.27M | 191.10K |
| Interest Income | 0.00 | 184.67K | 40.08K | 0.00 |
| Interest Expense | 374.57K | 184.67K | 40.08K | 0.00 |
| Depreciation & Amortization | 208.80K | 200.65K | 172.09K | 191.10K |
| EBITDA | -4.67M | -16.15M | -7.08M | 0.00 |
| EBITDA Ratio | -219.13% | -1,454.12% | 0.00% | 0.00% |
| Operating Income | -4.30M | -5.50M | -7.21M | -191.10K |
| Operating Income Ratio | -201.90% | -1,509.16% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.02M | -11.02M | -2.08M | 0.00 |
| Income Before Tax | -5.32M | -16.54M | -9.29M | -191.10K |
| Income Before Tax Ratio | -249.75% | -4,536.90% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -70.54K | -37.75K | 0.00 |
| Net Income | -5.32M | -16.47M | -9.25M | -191.10K |
| Net Income Ratio | -249.75% | -4,517.55% | 0.00% | 0.00% |
| EPS | -0.03 | -0.10 | -0.06 | 0.00 |
| EPS Diluted | -0.03 | -0.10 | -0.06 | 0.00 |
| Weighted Avg Shares Out | 187.68M | 169.65M | 147.04M | 87.10M |
| Weighted Avg Shares Out (Dil) | 187.68M | 169.65M | 147.04M | 87.10M |
Source: https://incomestatements.info
Category: Stock Reports